NK cell ontogeny and related markers
NK cell type | Markers | Transcription factor for progression | Next stage in the progression | Source |
---|---|---|---|---|
CLP | IL-7Rα, CD127, Lin– | NFIL3, GATA3, Id2 | Pro-B, Pre-T, ILCs, CD122+ early NKP lineage | Abel et al. [21] |
PreNKP | CD56–/16–,57–/T-bet–/Eomes–/ID2+ | - | NKP | Abel et al. [21] |
NKP | CD56–/16–,57–/T-bet–/Eomes–/CD122 | IL-15Rα | iNK | Sojka et al. [16] |
iNK | CD56–/16–,57–/T-bet–/Eomes–/NK1.1/NKG2D | NFIL3 | cNK | Sojka et al. [16] |
iNK | CD56–/16–,57–/T-bet–/Eomes– | NFIL3 | uNK | Sojka et al. [16] |
iNK | CD56–/16–,57–/T-bet–/Eomes– | T-bet | trNK liver | Simonetta et al. [22] |
iNK | CD56–/16–,57–/T-bet–/Eomes– | GATA3, IL-15 | Thymic NK | Sojka et al. [16] |
uNK | CD56bright/16–, 57–/49a+/T-bet+/Eomes++ | - | - | Simonetta et al. [22] |
Thymic NK | CD127+ | - | - | Sojka et al. [16] |
trNK liver | CD56bright/16–,57–/49a+/T-bet+/EOMES–/DX5– | - | - | Sojka et al. [16], Simonetta et al. [22] |
cNK | CD56bright/16–,57–/T-bet++/EOMES+++/CD49a–/DX5+ | IL-12, IL-15, IL-18 | Stage 5 cNK | Sojka et al. [16], Simonetta et al. [22] |
Stage 5 cNK | CD56dim/16+,57–/T-bet++/EOMES++ | - | Adaptive NK | Abel et al. [21] |
Adaptive NK | CD56dim/16+,57+/T-bet+++/EOMES+ | - | - | Abel et al. [21] |
NKG2D: NK group 2, member D; Lin: Lineage; -: none
TL wrote the first and final draft of the manuscript and the sections of the paper. Involved in writing various sections of the manuscript. JKK contributed to the conception and design of the paper. Additionally, she was involved in writing the final draft of various sections. KW wrote the section regarding angiogenesis. LA, AT, UG, SD and KB contributed to manuscript revision, read, and approved the submitted versions.
The authors declare they have no conflicts of interests.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
© The Author(s) 2022.